160 related articles for article (PubMed ID: 10917207)
1. Transformation-defective adenovirus 5 E1A mutants exhibit antioncogenic properties in human BLM melanoma cells.
Dickopp A; Esche H; Swart G; Seeber S; Kirch HC; Opalka B
Cancer Gene Ther; 2000 Jul; 7(7):1043-50. PubMed ID: 10917207
[TBL] [Abstract][Full Text] [Related]
2. Two domains within the adenovirus type 12 E1A unique spacer have disparate effects on the interaction of E1A with P105-Rb and the transformation of primary mouse cells.
Rumpf H; Esche H; Kirch HC
Virology; 1999 Apr; 257(1):45-53. PubMed ID: 10208919
[TBL] [Abstract][Full Text] [Related]
3. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
[TBL] [Abstract][Full Text] [Related]
4. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences.
Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW
Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the E1a gene of type 5 adenovirus result in oncogenic transformation of Fischer rat embryo cells.
Duigou GJ; Babiss LE; Liaw WS; Zimmer SG; Ginsberg HS; Fisher PB
J Cell Biochem; 1987 Feb; 33(2):117-26. PubMed ID: 3571338
[TBL] [Abstract][Full Text] [Related]
6. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
[TBL] [Abstract][Full Text] [Related]
7. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
Nevels M; Spruss T; Wolf H; Dobner T
Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
[TBL] [Abstract][Full Text] [Related]
8. Cancer therapy utilizing an adenoviral vector expressing only E1A.
Hubberstey AV; Pavliv M; Parks RJ
Cancer Gene Ther; 2002 Apr; 9(4):321-9. PubMed ID: 11960282
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of intratracheal lung cancer development by systemic delivery of E1A.
Chang JY; Xia W; Shao R; Hung MC
Oncogene; 1996 Oct; 13(7):1405-12. PubMed ID: 8875978
[TBL] [Abstract][Full Text] [Related]
10. Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines.
Buchou T; Kranenburg O; van Dam H; Roelen D; Zantema A; Hall FL; van der Eb A
Oncogene; 1993 Jul; 8(7):1765-73. PubMed ID: 8510923
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
[TBL] [Abstract][Full Text] [Related]
12. The C terminus of E1A regulates tumor progression and epithelial cell differentiation.
Fischer RS; Quinlan MP
Virology; 1998 Sep; 249(2):427-39. PubMed ID: 9791033
[TBL] [Abstract][Full Text] [Related]
13. In vivo antitumor effect of retrovirus-mediated gene transfer of the adenovirus E1a gene.
Sánchez-Prieto R; Quintanilla M; Martín P; Lleonart M; Cano A; Dotto GP; Ramón y Cajal S
Cancer Gene Ther; 1998; 5(4):215-24. PubMed ID: 9694073
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo.
Deng J; Xia W; Hung MC
Oncogene; 1998 Oct; 17(17):2167-75. PubMed ID: 9811448
[TBL] [Abstract][Full Text] [Related]
15. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous suppression of progression marker genes in the highly malignant human melanoma cell line BLM after transfection with the adenovirus-5 E1A gene.
van Groningen JJ; Cornelissen IM; van Muijen GN; Bloemers HP; Swart GW
Biochem Biophys Res Commun; 1996 Aug; 225(3):808-16. PubMed ID: 8780694
[TBL] [Abstract][Full Text] [Related]
17. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
18. E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer.
Fukuda K; Abei M; Ugai H; Seo E; Wakayama M; Murata T; Todoroki T; Tanaka N; Hamada H; Yokoyama KK
Cancer Res; 2003 Aug; 63(15):4434-40. PubMed ID: 12907616
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1A gene.
Sánchez-Prieto R; Quintanilla M; Cano A; Leonart ML; Martin P; Anaya A; Ramón y Cajal S
Oncogene; 1996 Sep; 13(5):1083-92. PubMed ID: 8806698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
